Inhalation route inducing subacute cutaneous lupus erythematosus with tiotropium.
Pham
Hoang-Chinh
HC
Saurat
Jean-Hilaire
JH
D000280:Administration, Inhalation; D001707:Biopsy, Needle; D019085:Fluorescent Antibody Technique, Direct; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000188:drug therapy*; D012075:Remission, Spontaneous; D018570:Risk Assessment; D012602:Scopolamine Derivatives / Q000008:administration & dosage / Q000009:adverse effects*; D012720:Severity of Illness Index; D000069447:Tiotropium Bromide
D012602:Scopolamine Derivatives; D000069447:Tiotropium Bromide